---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-029250"
form_type: "8-K"
ticker: "PCSA"
cik: "0001533743"
company_name: "Processa Pharmaceuticals, Inc."
filed_at: "2023-08-17T23:59:59+00:00"
generated_at: "2026-06-11T07:41:08.586598+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Processa presents at Sidoti conference; no material financial data disclosed

## Summary
- Company presented on August 17, 2023, at the Sidoti Micro-Cap Virtual Conference.
- David Young, Pharm.D., Ph.D., presented the corporate update during Track 2 at 11:30 AM ET.
- Presentation is available on Processa's website under the Investors section.
- No specific clinical trial results, financial guidance, or pipeline changes were detailed in the filing.

## SEC filing metadata
- accession: 0001493152-23-029250
- form_type: 8-K
- ticker: PCSA
- cik: 0001533743
- company_name: Processa Pharmaceuticals, Inc.
- filed_at: 2023-08-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533743/000149315223029250/0001493152-23-029250-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533743/000149315223029250/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-029250
- JSON: https://secwatch.observer/filing/0001493152-23-029250.json
- Plain text: https://secwatch.observer/filing/0001493152-23-029250.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.